Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'cohen' OR with Authors including 'cohen' OR with Abstract including 'cohen' OR with Keywords including 'cohen'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Cohen S, Fichman L, Eisne... Subjective reports of lysergic acid experiences in a context of psycho... Amer. J. Psychiat. 1958
Eisner BG, Cohen S Psychotherapy with lysergic acid diethylamide J Nerv Ment Dis 1958
Cohen S, Eisner BG Use of Lysergic acid diethylamide in a psychotherapeutic setting Arch.Neurol.Psychiat... 1959
Cohen S Notes on the LSD-25 state J.Wadsworht Gen.Hosp... 1959
Rosenbaum G, Cohen BD, Lu... Comparison of Sernyl with other drugs. Simulation of schizophrenic pe... A.M.A. Arch. Gen. Ps... 1959
Cohen S The therapeutic potential of LSD-25 A Pharmacologic Appr... 1959
Cohen S Lysergic acid diethylamide: side effects and complications J. Nerv. ment. Dis. 1960
Edwards AE, Cohen S Visual illusion, tactile sensibility and reaction time under LSD-25 Psychopharmacologia 1961
Cohen BD, Rosenbaum G, Lu... Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. ... Arch. gen.Psychiat. 1962
Cohen S, Ditman KS Complications associated with lysergic acid diethylamide (LSD-25) J Amer Med Ass 1962
Cohen S, Ditman KS Prolonged adverse reactions to lysergic acid diethylamide Arch. gen. Psychiat. 1963
McGlothlin WH, Cohen S, M... Short-term effects of LSD on Anxiety, Attitudes and performance J. Nerv. Ment. Dis. 1964
S Cohen What Price Morning Glory? Mind 1964
LA Cohen Hallucinogenic Spatial Disorientation Int. J. Neuropsychia... 1965
McGlothlin WH, Cohen S The Use of Hallucinogenic Drugs among College Students Amer. J. Psychiat. 1965
Cohen S Drugs of Hallucination; The Uses and Misuses of Lysergic Acid Diethyla...   1965
Cohen S The Beyond Within, the LSD Story   1965
Cohen S A classification of LSD complications Psychosomatics 1966
  LSD and chromosomes British Medical Jour... 1967
  Clinical value of LSD questioned; physical damage reported Journal of American ... 1967
McGlothlin W, Cohen S, Mc... Long lasting effects of LSD on normals Arch Gen Psychiat 1967
Hirschhorn K, Cohen MM Nonpsychic effects of lysergic acid diethylamide Ann. intern. med 1967
Cohen S Psychotherapy with LSD: pro and con 2nd International Co... 1967
Becker DE Some effects of lysergic acid diethylamide on visual discrimination in... Psychopharmacolgio 1967
Cohen S Lysergic acid diethylamide: psychiatric complications Psychosomatic medici... 1967
Cohen S Suicide or Accident? Amer. J. P:sychiat. 1967
McGlothlin W, Cohen S, Mc... Long lasting effects of LSD on normals Arch Gen Psychiat 1967
Cohen MM, Hirschhorn K, F... In vivo in vitro chromosomal damage induced by LSD-25 New Engl J Med 1967
Cohen MM, Marinello MJ, B... Chromosomal damage in human leukocytes induced by lysergic acid diethy... Science 1967
Ditman KS, Tietz W, Princ... Harmful aspects of the LSD experience J.nerv.ment.dis. 1968
Cohen M, Wakely H A comparative behavioral study of ditran and LSD in mice, rats and dog... Arch.int. Pharacodyn 1968
Cohen MM, Hirschhorn K, F... LSD and chromosomes New Engl J Med 1968
Ungerleider JT, Cohen S, ... The problems and prospects of LSD   1968
Cohen MM, Hirschhorn K, V... The effect of LSD-25 on the chromosomes of children exposed in utero Pediat. Res. 1968
Hirschhorn K, Cohen MM Drug-induced chromosomal aberrations Ann. N.Y. Acad. Sci. 1968
Cohen S The Cyclic Psychedelics Am J Psychiatry 1968
Sankar DVS, Rozsa PW, Gei... Chromosome Breakage in Children Treated with LSD-25 and UML-491 Comprehens. Psychiat... 1969
McGlothlin WH, Cohen S, M... Long-lasting effects of LSD on normals Drug Abuse, Social a... 1969
Cohen MM The interaction of various drugs with human chromosomes Canad. J. Genet. Cyt... 1969
Pahnke WN, Kurland AA, Go... LSD-assisted psychotherapy with terminal cancer patients Psychedelic Drugs 1969
Cohen MM "Genetic" disturbances associated with LSD Psychedelic drugs. 1969
Cohen S The personality of the user-before and after Psychedelic drugs. 1969
Pahnke WN, Kurland AA, Go... LSD-assisted psychotherapy with terminal cancer patients Curr Psychiatr Ther 1969
Asher H "Trailing" phenomenon - a long-lasting LSD side effect Am J Psychiatry 1971
Malleson N Acute adverse reactions to LSD in clinical and experimental use in the... Brit. J. Psychiat. 1971
Cohen S The psychotomimetic agents Progress in Drug Res... 1971
Egezcue J, Escude D LSD and Chromosomes Int Pharmacopsychiat 1972
Cohen M, Klein DF A measure of severity of multi-drug use among psychiatric patients Int. Pharmacopsychia... 1972
Muller DJ [ no Title ] Amer J Psychiat 1972
Cohen MM, Shiloh Y Genetic Toxicology Of Lysergic Acid Diethylamide (LSD-25) Mutation Research 1977
Cohen D LSD in Leiden New Scientist 1978
Cohen ML, Fuller RW Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine... Life Sci 1983
Aulakh CS, Cohen RM, Hill... Long-term imipramine treatment enhances locomotor and food intake supp... Br J Pharmacol 1987
Screaton GR, Singer M, Ca... Hyperpyrexia and rhabdomyolysis after MDMA ('ecstasy') abuse Lancet 1992
Cohen ML, Johnson MP, Sch... DOI and alpha-methylserotonin: comparative vascular and nonvascular sm... J Pharmacol Exp Ther 1993
Cohen RS Subjective reports on the effects of the MDMA ('ecstasy') experience i... Prog Neuropsychophar... 1995
Cohen RS Adverse symptomatology and suicide associated with the use of methylen... Biol Psychiatry 1996
Cohen RS, Cocores J Neuropsychiatric manifestations following the use of 3,4-methylenediox... Prog Neuropsychophar... 1997
Novak SJ LSD before Leary. Sidney Cohen's critique of 1950s psychedelic drug re... Isis 1997
Novak SJ Second thoughts on psychedelic drugs Endeavour 1998
Gijsman HJ, Verkes RJ, va... MDMA study Neuropsychopharmacol... 1999
Verkes RJ, Gijsman HJ, Pi... Cognitive performance and serotonergic function in users of ecstasy Psychopharmacology (... 2001
Klonoff-Cohen H, Lam-Krug... Maternal and paternal recreational drug use and sudden infant death sy... Arch Pediatr Adolesc... 2001
Gijsman HJ, Van Gerven JM... Saccadic peak velocity and EEG as end-points for a serotonergic challe... Hum Psychopharmacol 2002
Gowda RM, Cohen RA, Khan ... Toad venom poisoning: resemblance to digoxin toxicity and therapeutic ... Heart 2003
Lee DY, Karnati VV, He M,... Synthesis and in vitro pharmacological studies of new C(2) modified sa... Bioorg Med Chem Lett 2005
Lee DY, Ma Z, Liu-Chen LY... New neoclerodane diterpenoids isolated from the leaves of Salvia divin... Bioorg Med Chem 2005
Munro TA, Duncan KK, Xu W... Standard protecting groups create potent and selective kappa opioids: ... Bioorg Med Chem 2008
Chartoff EH, Potter D, Da... Exposure to the Selective kappa-Opioid Receptor Agonist Salvinorin A M... Neuropsychopharmacol... 2008
Zuurman L, Roy C, Schoema... Effect of intrapulmonary tetrahydrocannabinol administration in humans J Psychopharmacol 2008
Du Mont J, Macdonald S, R... Drug-facilitated sexual assault in Ontario, Canada: toxicological and ... J Forensic Leg Med 2010
Tai YF, Hoshi R, Brignell... Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDM... Neuropsychopharmacol... 2011
Mendelson JE, Coyle JR, L... Lack of effect of sublingual salvinorin A, a naturally occurring kappa... Psychopharmacology (... 2011
Rodgers J, Buchanan T, He... 'Ecstasy use, by itself, does not result in residual neurotoxicity'- a... Addiction 2011
Potter DN, Damez-Werno D,... Repeated Exposure to the kappa-Opioid Receptor Agonist Salvinorin A Mo... Biol Psychiatry 2011
Grunebaum MF, Galfalvy HC... Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression:... Am J Psychiatry 2017
Olmedo P, Goessler W, Tan... Metal Concentrations in e-Cigarette Liquid and Aerosol Samples: The Co... Environ Health Persp... 2018
Danforth AL, Grob CS, Str... Reduction in social anxiety after MDMA-assisted psychotherapy with aut... Psychopharmacology (... 2018